222 results on '"Beachler, Daniel C."'
Search Results
2. Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting
3. Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting
4. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases
5. Trends in the Completeness and Validity of Sources of Death Data Against the National Death Index From 2010 to 2018.
6. Risk of Anaphylaxis Among New Users of GLP-1 Receptor Agonists: A Cohort Study
7. Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: Post‐authorization safety study based on multinational cohorts
8. Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study
9. A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection.
10. Safety of Monovalent BNT162b2 (Pfizer–BioNTech), mRNA–1273 (Moderna), and NVX–CoV2373 (Novavax) COVID–19 Vaccines in US Children Aged 6 months to 17 years
11. The Natural History of Oral Human Papillomavirus in Young Costa Rican Women
12. Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study
13. Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years
14. Trends in cervical cancer incidence in younger US women from 2000 to 2013
15. A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer
16. Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents
17. Supplementary Table 2 from Risk Factors for Oral HPV Infection among a High Prevalence Population of HIV-Positive and At-Risk HIV-Negative Adults
18. Supplementary Table 1 from Risk Factors for Oral HPV Infection among a High Prevalence Population of HIV-Positive and At-Risk HIV-Negative Adults
19. Validation to Correct for Outcome Misclassification Bias
20. Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis
21. High Oral Human Papillomavirus Type 16 Load Predicts Long-term Persistence in Individuals With or at Risk for HIV Infection
22. Validation of an Algorithm for Claims-based Incidence of Prostate Cancer
23. Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting
24. Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting
25. Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals
26. Results of safety monitoring of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine in U.S. children aged 5-17 years
27. Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 years
28. Incidence of safety events after immune checkpoint inhibitor initiation for advanced-stage non-small-cell lung cancer: a real-world study
29. Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection
30. Natural History of Anal vs Oral HPV Infection in HIV-Infected Men and Women
31. Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer
32. Chronic Sinusitis and Risk of Head and Neck Cancer in the US Elderly Population
33. An Evaluation of the Effect of the OxyContin Reformulation on Unintentional Fatal and Nonfatal Overdose
34. Health care resource utilization and costs associated with advanced or metastatic nonsmall cell lung cancer in the United States
35. Elevated Risk of Myocarditis/Pericarditis Following COVID-19 mRNA Vaccination in the United States
36. Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring in the United States, 2019–2020
37. Response to Letter to the Editor regarding “Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data”
38. Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid Arthritis
39. Risk Factors for Acquisition and Clearance of Oral Human Papillomavirus Infection Among HIV-Infected and HIV-Uninfected Adults
40. 806-P: Risk of Acute Liver Injury in Real-World Use of Dapagliflozin
41. 805-P: Risk of Severe Complications of Urinary Tract Infection in Real-World Use of Dapagliflozin
42. 14-OR: Risk of Acute Kidney Injury in Real-World Use of Dapagliflozin
43. Development and validation of a predictive model algorithm to identify anaphylaxis in adults with type 2 diabetes in U.S. administrative claims data
44. Additional file 1 of Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study
45. Additional file 2 of A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer
46. Prior presumed coronavirus infection reduces COVID-19 risk: A cohort study
47. Testosterone Therapy in Relation to Prostate Cancer in a U.S. Commercial Insurance Claims Database
48. Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years.
49. Characteristics, treatment patterns, and survival from three cohorts of advanced or metastatic cancer patients using health care claims data in the United States.
50. Abstract 5050: Testosterone supplementation in relation to prostate cancer in a US commercial insurance claims database
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.